U.S. CAR-T Cell Therapy Market Size, Share & COVID-19 Impact Analysis, By Drug (Yescarta, Tecartus, Carvykti, Abecma, Breyanzi, Kymriah, and Others), By Indication (Acute Lymphoblastic Leukemia (ALL), Non-Hodgkin Lymphoma (NHL), and Multiple Myeloma), By End-user (Hospitals and Oncology Treatment Centers), and Country Forecast, 2023-2030
Last Updated: April 29, 2024 | Format: PDF | Report ID: FBI109015